Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
266.73
+0.78 (0.29%)
At close: Jul 28, 2026, 4:00 PM EDT
268.44
+1.71 (0.64%)
After-hours: Jul 28, 2026, 7:58 PM EDT
Johnson & Johnson Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 28, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 29, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Oct '23 Oct 1, 2023 | Jul '23 Jul 2, 2023 | Apr '23 Apr 2, 2023 | Jan '23 Jan 1, 2023 | Oct '22 Oct 2, 2022 | Jul '22 Jul 3, 2022 | Apr '22 Apr 3, 2022 | Jan '22 Jan 2, 2022 | Oct '21 Oct 3, 2021 |
Revenue Revenue Growth | 25,310 | 24,062 | 24,564 | 23,993 | 23,743 | 21,893 | 22,520 | 22,471 | 22,447 | 21,383 | 21,395 | 21,351 | 21,519 | 20,894 | 19,939 | 19,996 | 24,020 | 23,426 | 24,804 | 23,338 |
Revenue Growth | 6.60% | 9.91% | 9.08% | 6.77% | 5.77% | 2.38% | 5.26% | 5.25% | 4.31% | 2.34% | 7.30% | 6.78% | -10.41% | -10.81% | -19.61% | -14.32% | 3.04% | 4.95% | 10.36% | 10.70% |
Gross Profit Gross Profit Growth | 17,259 | 15,956 | 16,596 | 16,690 | 16,115 | 14,536 | 15,392 | 15,508 | 15,578 | 14,872 | 14,597 | 14,745 | 15,057 | 14,207 | 13,855 | 13,824 | 16,101 | 15,828 | 16,849 | 16,088 |
Operating Income Operating Income Growth | 7,174 | 6,359 | 5,510 | 7,096 | 6,710 | 6,199 | 3,624 | 5,078 | 6,263 | 6,073 | 4,249 | 5,692 | 5,958 | 5,797 | 4,633 | 5,364 | 6,172 | 5,818 | 5,412 | 5,766 |
Net Income Net Income Growth | 5,534 | 5,235 | 5,116 | 5,152 | 5,537 | 10,999 | 3,431 | 2,694 | 4,686 | 3,255 | 4,049 | 26,028 | 5,144 | -68 | 3,520 | 4,458 | 4,814 | 5,149 | 4,736 | 3,667 |
Earnings Per Share EPS Growth | 2.27 | 2.14 | 2.10 | 2.12 | 2.29 | 4.54 | 1.43 | 1.11 | 1.93 | 1.34 | 1.70 | 10.21 | 1.96 | -0.03 | 1.22 | 1.68 | 1.80 | 1.93 | 1.77 | 1.37 |
EPS Growth | -0.87% | -52.85% | 47.34% | 90.99% | 18.65% | 238.72% | -16.16% | -89.13% | -1.53% | - | 39.34% | 507.74% | 8.89% | - | -31.07% | 22.63% | -23.40% | -16.81% | 172.31% | 3.01% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 28, 2026 | Mar '26 Mar 29, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 28, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 29, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Oct '23 Oct 1, 2023 | Jul '23 Jul 2, 2023 | Apr '23 Apr 2, 2023 | Jan '23 Jan 1, 2023 | Oct '22 Oct 2, 2022 | Jul '22 Jul 3, 2022 | Apr '22 Apr 3, 2022 | Jan '22 Jan 2, 2022 | Oct '21 Oct 3, 2021 |
Innovative Medicine Innovative Medicine Growth | 16,384 | 15,426 | 15,763 | 15,563 | 15,202 | 13,873 | 14,332 | 14,580 | 14,490 | 13,562 | 13,722 | 13,893 | 13,731 | 13,413 | 13,163 | 13,214 | 13,317 | 12,869 | 14,217 | 12,882 |
MedTech MedTech Growth | 8,926 | 8,636 | 8,801 | 8,430 | 8,541 | 8,020 | 8,188 | 7,891 | 7,957 | 7,821 | 7,673 | 7,458 | 7,788 | 7,481 | 6,776 | 6,782 | 6,898 | 6,971 | 6,859 | 6,644 |
Revenue (Total) Revenue (Total) Growth | - | - | 24,564 | 23,993 | 23,743 | 21,893 | 22,520 | 22,471 | 22,447 | 21,383 | 21,395 | 21,351 | 21,519 | 20,894 | 19,939 | 19,996 | 24,020 | 23,426 | 24,804 | 23,338 |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 28, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 29, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Oct '23 Oct 1, 2023 | Jul '23 Jul 2, 2023 | Apr '23 Apr 2, 2023 | Jan '23 Jan 1, 2023 | Oct '22 Oct 2, 2022 | Jul '22 Jul 3, 2022 | Apr '22 Apr 3, 2022 | Jan '22 Jan 2, 2022 | Oct '21 Oct 3, 2021 |
Cash & Investments Cash & Investments Growth | 20,758 | 22,051 | 20,102 | 18,562 | 18,880 | 38,781 | 24,522 | 20,297 | 25,475 | 26,218 | 22,927 | 23,511 | 28,505 | 24,613 | 22,281 | 34,079 | 32,568 | 30,388 | 31,608 | 31,001 |
Total Debt Total Debt Growth | 49,036 | 54,987 | 47,933 | 45,795 | 50,761 | 52,252 | 36,634 | 35,751 | 41,491 | 33,632 | 29,332 | 29,921 | 45,602 | 52,907 | 39,642 | 32,027 | 32,597 | 33,148 | 33,751 | 33,928 |
Net Cash (Debt) Net Cash Growth | -28,278 | -32,936 | -27,831 | -27,233 | -31,881 | -13,471 | -12,112 | -15,454 | -16,016 | -7,414 | -6,405 | -6,410 | -17,097 | -28,294 | -17,361 | 2,052 | -29 | -2,760 | -2,143 | -2,927 |
Net Cash Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -11.59 | -13.47 | -11.41 | -11.21 | -13.18 | -5.56 | -5.03 | -6.37 | -6.61 | -3.05 | -2.60 | -2.51 | -6.51 | -10.86 | -6.55 | 0.77 | -0.01 | -1.04 | -0.80 | -1.09 |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 28, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 29, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Oct '23 Oct 1, 2023 | Jul '23 Jul 2, 2023 | Apr '23 Apr 2, 2023 | Jan '23 Jan 1, 2023 | Oct '22 Oct 2, 2022 | Jul '22 Jul 3, 2022 | Apr '22 Apr 3, 2022 | Jan '22 Jan 2, 2022 | Oct '21 Oct 3, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 8,616 | 2,514 | 7,309 | 9,169 | 3,878 | 4,174 | 6,983 | 7,993 | 5,633 | 3,657 | 7,863 | 7,489 | 4,182 | 3,257 | 5,350 | 6,284 | 5,581 | 3,979 | 5,732 | 8,290 |
Capital Expenditures CapEx Growth | -1,321 | -1,049 | -1,837 | -1,157 | -1,043 | -795 | -1,612 | -1,029 | -976 | -807 | -1,589 | -967 | -1,124 | -863 | -1,587 | -952 | -863 | -607 | -1,415 | -747 |
Free Cash Flow Free Cash Flow Growth | 7,295 | 1,465 | 5,472 | 8,012 | 2,835 | 3,379 | 5,371 | 6,964 | 4,657 | 2,850 | 6,274 | 6,522 | 3,058 | 2,394 | 3,763 | 5,332 | 4,718 | 3,372 | 4,317 | 7,543 |
Free Cash Flow Growth | 157.32% | -56.64% | 1.88% | 15.05% | -39.12% | 18.56% | -14.39% | 6.78% | 52.29% | 19.05% | 66.73% | 22.32% | -35.18% | -29.00% | -12.83% | -29.31% | 4.82% | -0.74% | -38.50% | -1.35% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 28, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 29, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Oct '23 Oct 1, 2023 | Jul '23 Jul 2, 2023 | Apr '23 Apr 2, 2023 | Jan '23 Jan 1, 2023 | Oct '22 Oct 2, 2022 | Jul '22 Jul 3, 2022 | Apr '22 Apr 3, 2022 | Jan '22 Jan 2, 2022 | Oct '21 Oct 3, 2021 |
Gross Margin | 68.19% | 66.31% | 67.56% | 69.56% | 67.87% | 66.40% | 68.35% | 69.01% | 69.40% | 69.55% | 68.23% | 69.06% | 69.97% | 68.00% | 69.49% | 69.13% | 67.03% | 67.57% | 67.93% | 68.93% |
Operating Margin | 28.34% | 26.43% | 22.43% | 29.58% | 28.26% | 28.32% | 16.09% | 22.60% | 27.90% | 28.40% | 19.86% | 26.66% | 27.69% | 27.74% | 23.24% | 26.83% | 25.70% | 24.84% | 21.82% | 24.71% |
Pretax Margin | 26.66% | 24.89% | 20.22% | 31.23% | 27.34% | 62.26% | 17.26% | 14.85% | 25.61% | 17.37% | 22.56% | 24.43% | 29.30% | -6.16% | 19.26% | 25.87% | 24.31% | 25.02% | 19.50% | 16.49% |
Profit Margin | 21.86% | 21.76% | 20.83% | 21.47% | 23.32% | 50.24% | 15.24% | 11.99% | 20.88% | 15.22% | 19.31% | 20.18% | 24.98% | -2.35% | 16.18% | 21.55% | 20.04% | 21.98% | 19.09% | 15.71% |
FCF Margin | 28.82% | 6.09% | 22.28% | 33.39% | 11.94% | 15.43% | 23.85% | 30.99% | 20.75% | 13.33% | 29.32% | 30.55% | 14.21% | 11.46% | 18.87% | 26.67% | 19.64% | 14.39% | 17.40% | 32.32% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 28, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 29, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Oct '23 Oct 1, 2023 | Jul '23 Jul 2, 2023 | Apr '23 Apr 2, 2023 | Jan '23 Jan 1, 2023 | Oct '22 Oct 2, 2022 | Jul '22 Jul 3, 2022 | Apr '22 Apr 3, 2022 | Jan '22 Jan 2, 2022 | Oct '21 Oct 3, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.340 | 1.300 | 1.300 | 1.300 | 1.300 | 1.240 | 1.240 | 1.240 | 1.240 | 1.190 | 1.190 | 1.190 | 1.190 | 1.130 | - | 1.130 | - | 1.060 | 1.060 | 1.060 |
Dividend Per Share Growth | 3.08% | 4.84% | 4.84% | 4.84% | 4.84% | 4.20% | 4.20% | 4.20% | 4.20% | 5.31% | - | 5.31% | - | 6.60% | - | 6.60% | - | 4.95% | 4.95% | 4.95% |
Dividend Yield | 0.52% | 0.52% | 0.62% | 0.72% | 0.85% | 0.74% | 0.86% | 0.77% | 0.85% | 0.75% | 0.76% | 0.73% | 0.72% | 0.73% | 0.63% | 0.69% | 0.63% | 0.59% | 0.61% | 0.66% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 28, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 29, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Oct '23 Oct 1, 2023 | Jul '23 Jul 2, 2023 | Apr '23 Apr 2, 2023 | Jan '23 Jan 1, 2023 | Oct '22 Oct 2, 2022 | Jul '22 Jul 3, 2022 | Apr '22 Apr 3, 2022 | Jan '22 Jan 2, 2022 | Oct '21 Oct 3, 2021 |
PE Ratio | 29.43 | 28.26 | 18.76 | 17.21 | 16.22 | 18.30 | 24.75 | 26.55 | 9.63 | 10.40 | 11.42 | 11.66 | 34.27 | 33.19 | 26.25 | 22.75 | 26.13 | 24.01 | 21.90 | 23.99 |
Forward PE | 21.57 | 20.82 | 18.78 | 16.49 | 14.45 | 15.49 | 14.42 | 16.29 | 13.90 | 14.85 | 15.05 | 14.98 | 15.63 | 14.74 | 17.49 | 16.07 | 17.52 | 16.93 | 16.98 | 16.36 |
P/FCF Ratio | 27.50 | 33.08 | 25.30 | 22.07 | 19.82 | 19.58 | 17.54 | 18.73 | 17.33 | 20.36 | 20.68 | 23.82 | 29.74 | 24.85 | 26.87 | 24.10 | 23.66 | 23.74 | 22.76 | 18.81 |
PS Ratio | 6.25 | 6.10 | 5.29 | 4.69 | 4.06 | 4.47 | 3.92 | 4.43 | 4.06 | 4.45 | 4.43 | 4.48 | 5.25 | 4.75 | 5.77 | 4.63 | 4.94 | 4.94 | 5.71 | 4.62 |